Gland Pharma shares plunge 12% in the present day: Must you purchase, maintain or promote?
Shares of Gland Pharma dropped 12 per cent in Thursday's commerce after brokerages minimize their earnings forecasts for the drug maker following its September quarter outcomes, and 'uninspiring outlook'.
The drug maker reported a 20…